A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients-Reference-Cited by-同舟云学术

A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients

Published:2009-01-28 Issue:3 Volume:23 Page:357-368
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Demeter Lisa M,Jiang Hongyu,Mukherjee A Lisa,Morse Gene D,DiFrancesco Robin,DiCenzo Robert,Dykes Carrie,Sista Prakash,Bacheler Lee,Klingman Karin,Rinehart Alex,Albrecht Mary

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference30 articles.

1. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel;Hammer;JAMA,2006

2. Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection;Colombo;Antimicrob Agents Chemother,2006

3. Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study;Durant;AIDS,2000

4. Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia;Shulman;Antimicrob Agents Chemother,2002

5. Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients;Hsu;Antimicrob Agents Chemother,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice;Current HIV Research;2019-10-23

2. Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients;Expert Review of Clinical Pharmacology;2016-09-23

3. Therapeutic Drug Monitoring of Antiretrovirals;Clinical Challenges in Therapeutic Drug Monitoring;2016

4. Peripheral neuropathy in ART-experienced patients: prevalence and risk factors;Journal of NeuroVirology;2013-12

5. Discordant Associations Between SLCO1B1 521T→C and Plasma Levels of Ritonavir-boosted Protease Inhibitors in AIDS Clinical Trials Group Study A5146;Therapeutic Drug Monitoring;2013-04